Glial interference: impact of type I interferon in neurodegenerative diseases

Mol Neurodegener. 2022 Nov 26;17(1):78. doi: 10.1186/s13024-022-00583-3.

Authors

Ethan Roy¹, Wei Cao²

Affiliations

¹ Department of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.
² Department of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, 77030, USA. wei.cao@uth.tmc.edu.

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural

MeSH terms

Humans
Interferon Type I*
Neurodegenerative Diseases*
Neuroglia

Substances

Interferon Type I